Application of metagenomic next-generation sequencing in patients with infective endocarditis

被引:7
|
作者
Li, Shao-Lin [1 ]
Zhao, Xi [1 ]
Tao, Jun-Zhong [1 ]
Yue, Zhen-Zhen [1 ]
Zhao, Xiao-Yan [1 ]
机构
[1] Zhengzhou Univ, Cardiovasc Ctr, Dept Cardiol, Henan Key Lab Hereditary Cardiovasc Dis,Affiliated, Zhengzhou, Henan, Peoples R China
关键词
metagenomic next-generation sequencing; infective endocarditis; culture-negative; culture-positive; antibiotic regimen; CULTURE-NEGATIVE ENDOCARDITIS; CHALLENGES; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1107170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesMetagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis. MethodsThe present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed. ResultsExcept for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS. ConclusionsCulture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Application of Metagenomic Next-Generation Sequencing in Suspected Spinal Infectious Diseases
    Li, Cheng
    Xiao, Nian-su
    Ke, Bao-yi
    Li, Sen
    Lin, Yang
    WORLD NEUROSURGERY, 2024, 185 : E542 - E548
  • [32] Application of metagenomic next-generation sequencing in bloodstream infection regarding immunosuppression
    Li, Hao
    Ge, Tong
    Huang, Meijuan
    Zhang, Wenqian
    Li, Zewei
    Xiao, Min
    Gao, Lili
    JOURNAL OF INFECTION, 2023, 86 (05) : 508 - 512
  • [33] Application of metagenomic next-generation sequencing in the detection of pathogens in spinal infections
    Wang, Guanzhong
    Long, Jiang
    Zhuang, Yong
    Leng, Xue
    Zhang, Yaqing
    Liu, Libangxi
    Fu, Jiawei
    Chen, Yu
    Li, Changqing
    Zhou, Yue
    Huang, Bo
    Feng, Chencheng
    SPINE JOURNAL, 2023, 23 (06): : 859 - 867
  • [34] Application of metagenomic next-generation sequencing for suspected infected pancreatic necrosis
    Lin, Chiayen
    Bonsu, Abdul Aziz F. K.
    Li, Jiarong
    Ning, Caihong
    Chen, Lu
    Zhu, Shuai
    Zhong, Qiaoqing
    Shen, Dingcheng
    Huang, Gengwen
    PANCREATOLOGY, 2022, 22 (07) : 864 - 870
  • [35] APPLICATION OF METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) IN DIAGNOSING PNEUMONIA OF CHILDREN
    Guo, Y.
    Yang, A.
    Chen, C.
    Hu, Y.
    Zheng, G.
    Xie, Z.
    Fan, H.
    Sun, Y.
    Xia, H.
    Yin, G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [36] Clinical Application of Metagenomic Next-Generation Sequencing in Patients with Hematologic Malignancies Suffering from Sepsis
    Liu, Wang-Da
    Yen, Ting-Yu
    Liu, Po-Yo
    Wu, Un-In
    Bhan, Prerana
    Li, Yu-Chi
    Chi, Chih-Hung
    Sheng, Wang-Huei
    MICROORGANISMS, 2021, 9 (11)
  • [37] The microbiological diagnostic performance of metagenomic next-generation sequencing in patients with sepsis
    Di Ren
    Chao Ren
    Renqi Yao
    Lin Zhang
    Xiaomin Liang
    Guiyun Li
    Jiaze Wang
    Xinke Meng
    Jia Liu
    Yu Ye
    Haoli Li
    Sha Wen
    Yanhong Chen
    Dan Zhou
    Xisi He
    Xiaohong Li
    Kai Lai
    Ying Li
    Shuiqing Gui
    BMC Infectious Diseases, 21
  • [39] Clinical Application of Metagenomic Next-Generation Sequencing for Suspected Infections in Patients With Primary Immunodeficiency Disease
    Tang, Wenjing
    Zhang, Yu
    Luo, Chong
    Zhou, Lina
    Zhang, Zhiyong
    Tang, Xuemei
    Zhao, Xiaodong
    An, Yunfei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Diagnostic Value and Clinical Application of Metagenomic Next-Generation Sequencing for Infections in Critically Ill Patients
    He, Yuxi
    Geng, Shike
    Mei, Qing
    Zhang, Lei
    Yang, Tianjun
    Zhu, Chunyan
    Fan, Xiaoqin
    Wang, Yinzhong
    Tong, Fei
    Gao, Yu
    Fang, Xiaowei
    Bao, Renren
    Sheng, Ximei
    Pan, Aijun
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6309 - 6322